These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25629170)

  • 1. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.
    Hoffmann TJ; Sakoda LC; Shen L; Jorgenson E; Habel LA; Liu J; Kvale MN; Asgari MM; Banda Y; Corley D; Kushi LH; Quesenberry CP; Schaefer C; Van Den Eeden SK; Risch N; Witte JS
    PLoS Genet; 2015 Jan; 11(1):e1004930. PubMed ID: 25629170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
    Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
    Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
    Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
    Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.
    Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB
    Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
    Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
    Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.
    Beebe-Dimmer JL; Hathcock M; Yee C; Okoth LA; Ewing CM; Isaacs WB; Cooney KA; Thibodeau SN
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1366-72. PubMed ID: 26108461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.
    Breyer JP; Avritt TG; McReynolds KM; Dupont WD; Smith JR
    Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1348-53. PubMed ID: 22714738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.
    Beebe-Dimmer JL; Isaacs WB; Zuhlke KA; Yee C; Walsh PC; Isaacs SD; Johnson AM; Ewing CE; Humphreys EB; Chowdhury WH; Montie JE; Cooney KA
    BJU Int; 2014 May; 113(5):830-5. PubMed ID: 24148311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in Polish men.
    Heise M; Jarzemski P; Bąk A; Junkiert-Czarnecka A; Pilarska-Deltow M; Haus O
    Pol J Pathol; 2019; 70(2):127-133. PubMed ID: 31556563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis.
    Huang H; Cai B
    Tumour Biol; 2014 Feb; 35(2):1177-82. PubMed ID: 24026887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
    Xu J; Lange EM; Lu L; Zheng SL; Wang Z; Thibodeau SN; Cannon-Albright LA; Teerlink CC; Camp NJ; Johnson AM; Zuhlke KA; Stanford JL; Ostrander EA; Wiley KE; Isaacs SD; Walsh PC; Maier C; Luedeke M; Vogel W; Schleutker J; Wahlfors T; Tammela T; Schaid D; McDonnell SK; DeRycke MS; Cancel-Tassin G; Cussenot O; Wiklund F; Grönberg H; Eeles R; Easton D; Kote-Jarai Z; Whittemore AS; Hsieh CL; Giles GG; Hopper JL; Severi G; Catalona WJ; Mandal D; Ledet E; Foulkes WD; Hamel N; Mahle L; Moller P; Powell I; Bailey-Wilson JE; Carpten JD; Seminara D; Cooney KA; Isaacs WB;
    Hum Genet; 2013 Jan; 132(1):5-14. PubMed ID: 23064873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.
    Storebjerg TM; Høyer S; Kirkegaard P; Bro F; ; Ørntoft TF; Borre M; Sørensen KD
    BJU Int; 2016 Oct; 118(4):646-53. PubMed ID: 26779768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial.
    Chen Z; Greenwood C; Isaacs WB; Foulkes WD; Sun J; Zheng SL; Condreay LD; Xu J
    Carcinogenesis; 2013 Jun; 34(6):1260-4. PubMed ID: 23393222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXB13 mutations in a population-based, case-control study of prostate cancer.
    Stott-Miller M; Karyadi DM; Smith T; Kwon EM; Kolb S; Stanford JL; Ostrander EA
    Prostate; 2013 May; 73(6):634-41. PubMed ID: 23129385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy.
    Schroeck FR; Zuhlke KA; Siddiqui J; Siddiqui R; Cooney KA; Wei JT
    J Urol; 2013 Mar; 189(3):849-53. PubMed ID: 23036981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
    Smith SC; Palanisamy N; Zuhlke KA; Johnson AM; Siddiqui J; Chinnaiyan AM; Kunju LP; Cooney KA; Tomlins SA
    Am J Surg Pathol; 2014 May; 38(5):615-26. PubMed ID: 24722062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between germline HOXB13 G84E mutation and risk of prostate cancer.
    Akbari MR; Trachtenberg J; Lee J; Tam S; Bristow R; Loblaw A; Narod SA; Nam RK
    J Natl Cancer Inst; 2012 Aug; 104(16):1260-2. PubMed ID: 22781434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E.
    MacInnis RJ; Severi G; Baglietto L; Dowty JG; Jenkins MA; Southey MC; Hopper JL; Giles GG
    PLoS One; 2013; 8(2):e54727. PubMed ID: 23457453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.
    Handorf E; Crumpler N; Gross L; Giri VN
    J Genet Couns; 2014 Jun; 23(3):371-6. PubMed ID: 24310616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of homeobox protein B13 (HOXB13) gene G84E mutation in patients with prostate cancer.
    Bıyıkoğlu M; Tanrıverdi R; Bozlu M; Şenel S; Fidancı ŞB; Tamer L; Akbay E
    World J Urol; 2024 Aug; 42(1):476. PubMed ID: 39115757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.